Page last updated: 2024-08-23

ursodeoxycholic acid and Necrosis

ursodeoxycholic acid has been researched along with Necrosis in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (31.58)18.2507
2000's9 (47.37)29.6817
2010's2 (10.53)24.3611
2020's2 (10.53)2.80

Authors

AuthorsStudies
Chen, Y; Duan, Y; Han, J; Liu, L; Yang, S; Yang, X; Zhang, S1
Behar-Cohen, F; Berdugo, M; Bertrand, M; Boatright, J; Daruich, A; Delaunay, K; Henry, H; Jaworski, T; Kowalczuk, L; Naud, MC; Parenti, L; Picard, E; Youale, J; Zola, M1
Choi, JE; Han, SI; Kang, HS; Lim, SC; Si, H1
Choi, JE; Duong, HQ; Han, SI; Kang, JH; Lee, TB; Lim, SC; Oh, SH1
Denk, H; Fickert, P; Fuchsbichler, A; Lammert, F; Marschall, HU; Stumptner, C; Trauner, M; Tsybrovskyy, O; Weiglein, AH; Zatloukal, K; Zollner, G1
Forget, PP; Heemskerk, J; Heineman, E; Sie, GH; Van den Neucker, AM; van Heurn, LW1
Ribal'chenko, VK; Sinel'nik, OD; Sinel'nik, TB1
Holy, JM; Palmeira, CM; Rolo, AP; Wallace, KB1
Angulo, P; Burgart, L; Colin, P; Harrison, ME; Heathcote, EJ; Jorgensen, R; Kowdley, KV; Lindor, KD; Lymp, JF1
Chrétien, Y; Corpechot, C; Galotte, M; Poujol-Robert, A; Poupon, R; Poupon, RE; Wendum, D1
Ballestero, MR; Briz, O; Marin, JJ; Monte, MJ; Perez, MJ1
Attia, M; Badran, HM; Barakat, E; El-Nakeeb, A; El-Tawil, A; El-Zayadi, AR; Saied, A; Selim, O; Zalata, K1
Batta, AK; Chen, T; Kren, BT; Nguyen, LB; Salen, G; Shefer, S; Steer, CJ; Tint, GS1
Antezana, C; Brahm, J; Cumsille, MA; González-Koch, A; Smok, G1
Aguilar, HI; Botla, R; Bronk, SF; Gores, GJ; Miyoshi, H1
Angulo, P; Batts, KP; Larson, DR; LaRusso, NF; Lindor, KD; Therneau, TM1
Carrat, F; Corpechot, C; Poupon, R; Poupon, RE1
Heuman, DM; Hylemon, PB; Pandak, WM; Vlahcevic, ZR1
Heuman, DM; Hylemon, PB; McCall, J; Mills, AS; Pandak, WM; Vlahcevic, ZR1

Reviews

1 review(s) available for ursodeoxycholic acid and Necrosis

ArticleYear
[Bile acids in the process of canalicular bile formation].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2003, Volume: 49, Issue:6

    Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Bile Canaliculi; Biological Transport, Active; Cholestasis; Gene Expression Regulation; Hepatocytes; Humans; Hydrophobic and Hydrophilic Interactions; Membrane Transport Proteins; Necrosis; Ursodeoxycholic Acid

2003

Trials

3 trial(s) available for ursodeoxycholic acid and Necrosis

ArticleYear
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
    Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:3

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Disease Progression; Double-Blind Method; Fatty Liver; Fibrosis; Humans; Liver; Necrosis; Ursodeoxycholic Acid

2004
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:4

    Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Necrosis; Protective Agents; Ribavirin; RNA, Viral; Silymarin; Treatment Outcome; Ursodeoxycholic Acid

2005
The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.
    Journal of hepatology, 1997, Volume: 27, Issue:1

    Topics: Adult; Aged; Cholagogues and Choleretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Liver; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Necrosis; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid

1997

Other Studies

15 other study(ies) available for ursodeoxycholic acid and Necrosis

ArticleYear
A novel therapy for hepatic cholestasis treatment-the combination of rosiglitazone and fenofibrate.
    European journal of pharmacology, 2023, Jan-05, Volume: 938

    Topics: Animals; Cholestasis; Fenofibrate; Liver; Mice; Mice, Inbred C57BL; Necrosis; Rosiglitazone; Ursodeoxycholic Acid

2023
Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:2

    Topics: Administration, Oral; Albumins; Animals; Apoptosis; Biological Availability; Blood-Retinal Barrier; Cell Line; Cholagogues and Choleretics; Cryosurgery; Female; Humans; In Vitro Techniques; Laser Therapy; Male; Middle Aged; Necrosis; Photoreceptor Cells, Vertebrate; Rats; Retina; Retinal Cone Photoreceptor Cells; Retinal Degeneration; Retinal Detachment; Subretinal Fluid; Ursodeoxycholic Acid; Vitrectomy

2021
Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    International journal of cancer, 2010, Apr-01, Volume: 126, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Caspase 8; Cholagogues and Choleretics; Electrophoretic Mobility Shift Assay; Hep G2 Cells; HT29 Cells; Humans; L-Lactate Dehydrogenase; Liver Neoplasms; Necrosis; Organoplatinum Compounds; Oxaliplatin; Reactive Oxygen Species; RNA, Small Interfering; Tumor Suppressor Protein p53; Ursodeoxycholic Acid

2010
Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Carcinogenesis, 2011, Volume: 32, Issue:5

    Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cholagogues and Choleretics; Humans; Membrane Microdomains; Mice; Mice, Inbred BALB C; Necrosis; Protein Kinase C-delta; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Stomach Neoplasms; Tumor Cells, Cultured; Ursodeoxycholic Acid

2011
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
    Gastroenterology, 2002, Volume: 123, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Bile; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Extrahepatic; Common Bile Duct; Disease Models, Animal; Infarction; Ligation; Male; Mice; Mice, Knockout; Necrosis; Pressure; Ursodeoxycholic Acid

2002
Extreme short bowel syndrome in a full-term neonate--a case report.
    Journal of pediatric surgery, 2003, Volume: 38, Issue:11

    Topics: Anastomosis, Surgical; Breast Feeding; Cholagogues and Choleretics; Cholestasis; Diarrhea, Infantile; Humans; Infant, Newborn; Intestinal Volvulus; Intestines; Liver Function Tests; Male; Necrosis; Parenteral Nutrition; Short Bowel Syndrome; Steatorrhea; Ursodeoxycholic Acid

2003
Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 79, Issue:1

    Topics: Adenosine Triphosphate; Apoptosis; Bile Acids and Salts; Bromodeoxyuridine; Caspase 9; Caspases; Cell Cycle; Cell Division; Cell Line; Cell Membrane Permeability; Cell Survival; Chenodeoxycholic Acid; Chromatin; Cytochromes c; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Synergism; Humans; Mitochondrial Diseases; Necrosis; Poly(ADP-ribose) Polymerases; Taurochenodeoxycholic Acid; Time Factors; Tubulin; Ursodeoxycholic Acid

2004
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:3

    Topics: Aspartate Aminotransferases; Bile Ducts, Intrahepatic; Bilirubin; Biomarkers; Cholagogues and Choleretics; Female; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Lymphocytes; Male; Middle Aged; Necrosis; Predictive Value of Tests; Sensitivity and Specificity; Ursodeoxycholic Acid

2004
Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Adducts; DNA Fragmentation; Humans; Intestinal Neoplasms; Intestine, Small; Male; Mice; Necrosis; Organoplatinum Compounds; Ursodeoxycholic Acid

2005
Regulation of bile acid synthesis by deoxycholic acid in the rat: different effects on cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase.
    Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:4 Pt 1

    Topics: Animals; Bile; Bile Acids and Salts; Cell Nucleus; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestanetriol 26-Monooxygenase; Cholesterol 7-alpha-Hydroxylase; Cytochrome P-450 Enzyme System; Deoxycholic Acid; Diet; Hydroxymethylglutaryl CoA Reductases; Liver; Liver Diseases; Male; Necrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid Hydroxylases; Ursodeoxycholic Acid

1995
Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases.
    Biochimica et biophysica acta, 1998, Aug-10, Volume: 1366, Issue:1-2

    Topics: Animals; ATP-Dependent Proteases; Calcium Channels; Calpain; Cholestasis; Enzyme Activation; Glycochenodeoxycholic Acid; Liver; Mitochondria, Liver; Necrosis; Permeability; Serine Endopeptidases; Ursodeoxycholic Acid

1998
Time course of histological progression in primary sclerosing cholangitis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Adolescent; Adult; Aged; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Female; Follow-Up Studies; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Markov Chains; Middle Aged; Necrosis; Penicillamine; Time Factors; Treatment Outcome; Ursodeoxycholic Acid

1999
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.
    Gastroenterology, 2002, Volume: 122, Issue:3

    Topics: Bilirubin; Cholagogues and Choleretics; Disease Progression; Female; Humans; Incidence; Liver; Liver Cirrhosis, Biliary; Male; Markov Chains; Middle Aged; Multivariate Analysis; Necrosis; Predictive Value of Tests; Prognosis; Risk Factors; Serum Albumin; Ursodeoxycholic Acid

2002
Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes.
    Hepatology (Baltimore, Md.), 1991, Volume: 14, Issue:5

    Topics: Animals; Bile Acids and Salts; Cell Survival; Cells, Cultured; Erythrocytes; Humans; Liver; Necrosis; Rats; Ursodeoxycholic Acid

1991
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
    Gastroenterology, 1991, Volume: 100, Issue:1

    Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid

1991